[Clinical and biological aspects of liver damage in infectious mononucleosis].
Liver damage, clinical manifest or inapparent is a frequent manifestation of infectious mononucleosis. This study has in view the forms and frequency of manifestation of liver damage in infectious mononucleosis. The retrospective study has included 115 patients with infectious mononucleosis, hospitalised in Braşov Infectious Diseases Hospital between 1.01.1998 and 31.12.2002. The enlargement of the liver as unique manifestation in liver damage was noticed in 27% of the cases; jaundice of the skin and sclerae in 10.4% of the cases; infectious mononucleosis hepatitis in 55.6% of the cases; and in 11.3% of cases high serum levels of GPT were noted. The levels of serum protein were also affected, low-grade increase of protein serum levels--18.2% of the cases, hypoalbuminemia--82.4% of cases and subunitary albumin/globulin ratio in 70.3% of the cases. All these levels might be indicators for liver damage.
Cocuz
Maria-Elena
ME
Universitatea Transilvania Braşov.
Idomir
Mihaela Elena
ME
Ticău
Oana Cristina
OC
D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers / Q000097:blood; D006505:Hepatitis / Q000097:blood / Q000821:virology*; D006529:Hepatomegaly / Q000821:virology; D006801:Humans; D034141:Hypoalbuminemia / Q000097:blood; D007244:Infectious Mononucleosis / Q000097:blood / Q000150:complications* / Q000175:diagnosis; D007565:Jaundice / Q000821:virology; D012189:Retrospective Studies; D012709:Serum Albumin / Q000378:metabolism; D012712:Serum Globulins / Q000378:metabolism
D015415:Biomarkers; D012709:Serum Albumin; D012712:Serum Globulins; D001219:Aspartate Aminotransferases